Page last updated: 2024-09-05

lenalidomide and Anemia, Hypoplastic

lenalidomide has been researched along with Anemia, Hypoplastic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schleiffenbaum, BE	1
Alexandrescu, DT; Dasanu, CA	1

Other Studies

2 other study(ies) available for lenalidomide and Anemia, Hypoplastic

Article	Year
[CME myelodysplasia - a frequent hematologic neoplasia in the elderly]. Praxis, 2014, May-21, Volume: 103, Issue:11 Topics: Aged, 80 and over; Anemia, Aplastic; Azacitidine; Bone Marrow; Bone Marrow Examination; Cell Proliferation; Cell Transformation, Neoplastic; Decitabine; Diagnosis, Differential; Disease Progression; Hematopoiesis; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Prognosis; Thalidomide	2014
A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. European journal of haematology, 2009, Volume: 82, Issue:3 Topics: Anemia, Aplastic; Antineoplastic Agents; Biopsy; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Thalidomide	2009

Article

Year

[CME myelodysplasia - a frequent hematologic neoplasia in the elderly].

Praxis, 2014, May-21, Volume: 103, Issue:11

Topics: Aged, 80 and over; Anemia, Aplastic; Azacitidine; Bone Marrow; Bone Marrow Examination; Cell Proliferation; Cell Transformation, Neoplastic; Decitabine; Diagnosis, Differential; Disease Progression; Hematopoiesis; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Prognosis; Thalidomide

2014

A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.

European journal of haematology, 2009, Volume: 82, Issue:3

Topics: Anemia, Aplastic; Antineoplastic Agents; Biopsy; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Thalidomide

2009